Tedizolid
Top View
- Introduction and Geographic Availability of New Antibiotics Approved Between 1999 and 2014
- AST News Update, Volume 6, Issue 1 – April 2021
- A Review of US Food and Drug Administration–Approved Antibiotics
- Gram-Positive Recs for Use for Newer MRSA Agents
- Tedizolid (Sivextro®)
- Sivextro, Tedizolid Phosphate
- Real-Life Evidence for Tedizolid Phosphate in the Treatment of Cellulitis and Wound Infections: a Case Series
- R.1.1.2. Anchetă Transversală Privind Utilizarea Preparatelor Antimicrobiene În Lanțul Trofic (Cod - PN-III-P1-1.2-PCCDI-2017-0361)
- Successful Treatment of Soft Tissue Mycobacterium Chelonae Infection with a Tedizolid-Containing Regimen Daniel Henery, DO, Adam C
- SIVEXTRO (Tedizolid Phosphate) for Injection, for Intravenous Use Been Adequately Evaluated
- Diagnosing and Managing Nontuberculous Mycobacteria
- NORM/NORM-VET 2017 Should Include Specific Reference to This Report
- Astrazeneca Manuscript Antibiotic Protection Goals for the Environment
- Managing Side Effects
- Here Are Less Than Three Participating Hospitals for Your Country for the Reported Year, Results at Country Level Are Not Displayed
- Drug Resistance Updates 40 (2018) 25–39
- Sivextro (Tedizolid) C9353-A
- New Insights Into Tedizolid Efficacy Against Staphylococci